Thomas D'Aunno
Thomas D'Aunno
Professor of Public Health, NYU School of Global Public Health
Professor of Management, NYU Wagner Graduate School of Public Service
-
Professional overview
-
Thomas D'Aunno, Ph.D., is Professor of Management at New York University’s Wagner Graduate School of Public Service and Professor of Public Health at NYU’s School of Global Public Health. His research interests include institutional theory, organizational change, and the performance of healthcare organizations. D’Aunno was previously a faculty member at Columbia University, the University of Chicago, the University of Michigan, and INSEAD, where he held the Novartis Chair in Healthcare Management. He is published in leading management and health journals, including Administrative Science Quarterly, the Academy of Management Journal, Academy of Management Review, Annals of the Academy of Management, the Journal of the American Medical Association, Milbank Quarterly, American Journal of Public Health and Health Affairs. He served as Editor-in-Chief of Medical Care Research and Review, 2014-2018. He also is a past chair of the Academy of Management Division of Health Care Management, and a recipient of its Provan Award for distinguished career contributions to research in healthcare management and the Fottler award for distinguished service to the field.
-
Education
-
Ph.D., Organizational Psychology, University of Michigan, Ann Arbor, MichiganUniversity of Maryland, Community-Clinical Psychology, Baltimore County, MarylandB.A., Psychology, Magna Cum Laude, University of Notre Dame, Notre Dame, Indiana
-
Publications
Publications
Lessons from New York City's Response to the Coronavirus Pandemic
Failed retrieving data.Patient-centered care's relationship with substance use disorder treatment utilization
Failed retrieving data.Stability in a large drug treatment system : Examining the role of program size and performance on service discontinuation
Failed retrieving data.Evidence-based treatment for opioid use disorders : A national study of methadone dose levels, 2011–2017
Failed retrieving data.Medicaid coverage in substance use disorder treatment after the affordable care act
Failed retrieving data.Motivating people
Failed retrieving data.Sustaining multistakeholder alliances
Failed retrieving data.The relationship of Medicaid expansion to psychiatric comorbidity care within substance use disorder treatment programs
Failed retrieving data.Do benefits restrictions limit Medicaid acceptance in addiction treatment? : Results from a national study
Failed retrieving data.Factors That Distinguish High-Performing Accountable Care Organizations in the Medicare Shared Savings Program
Failed retrieving data.State-Targeted funding and technical assistance to increase access to medication treatment for opioid use disorder
Failed retrieving data.The Hidden Roles That Management Partners Play in Accountable Care Organizations
Failed retrieving data.Trust, Money, and Power : Life Cycle Dynamics in Alliances Between Management Partners and Accountable Care Organizations
Failed retrieving data.A behavioral blueprint for improving health care policy
Failed retrieving data.Corrigendum to “Evidence-based treatment for opioid disorders : A 23-year national study of methadone dose levels” [Journal of Substance Abuse Treatment 47 (2014) 245–250](S0740547214000907)(10.1016/j.jsat.2014.06.001)
Failed retrieving data.Creating value for participants in multistakeholder alliances : The shifting importance of leadership and collaborative decision-making over time
Failed retrieving data.Evidence-Based Management in Healthcare : Principles, Cases, and Perspectives
Failed retrieving data.Linkages between patient-centered medical homes and addiction treatment organizations
Failed retrieving data.Practice environments and job satisfaction and turnover intentions of nurse practitioners : Implications for primary care workforce capacity
Failed retrieving data.The affordable care act transformation of substance use disorder treatment
Failed retrieving data.The Role of Program Directors in Treatment Practices : The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs
Failed retrieving data.Hepatitis C testing in substance use disorder treatment : The role of program managers in adoption of testing services
Failed retrieving data.Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs
Failed retrieving data.On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs : Study protocol for a hybrid design randomized controlled trial
Failed retrieving data.Spillover effects of HIV testing policies : Changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States
Failed retrieving data.